Live
- Phase 1 polls in 102 seats across 21 states today
- 39 candidates file papers on Day 1
- ED arrests AAP MLA Amanatullah Khan in Waqf Board appointment scam
- LS polls: Union Minister Bhagwanth Khuba, Dingaleshwara seer, Priyanka Jarkiholi file nominations in K'taka
- Amid show of strength, Congress’ Praniti Shinde files nomination from Solapur
- Tamil Nadu Police gives clean report to Isha Foundation in missing volunteers case
- Home Minister Amit Shah to address public meeting in Goa on April 24
- Gurgaon Open: M Dharma fires 67 for two-shot lead on penultimate day
- Sharad Pawar made many attempts to finish Shiv Sena, claims Maha minister
- Former England opener Raman Subba Row dies aged 92
Suven Life gets patent for neurological drug
City-based Suven Life Sciences has received a patent from New Zealand for a drug used for treatment of neuro-degenerative diseases, according to a company’s communique to BSE.
Hyderabad: City-based Suven Life Sciences has received a patent from New Zealand for a drug used for treatment of neuro-degenerative diseases, according to a company’s communique to BSE. The patents are valid till 2034. The drug major has been approved for its one product patent from New Zealand corresponding to the New Chemical Entities (NCEs) for the treatment of disorders associated with neuro-degenerative diseases.
Venkat Jasti, CEO, Suven Life, said: “We’re very pleased by the grant of these patents to Suven for our pipeline of molecules in the CNS arena, which are being developed for cognitive disorders with high unmet medical need with a huge market potential globally.” Suven Life Sciences witnessed its stock soaring 10 percent up in the morning trade after the news hit the market.
